Results 151 to 160 of about 39,060 (295)

Microbial Endocrinology Redefines Prostate Cancer - The Bugs That Outwit Androgen Deprivation. [PDF]

Transl Oncol
Asim M.
europepmc   +1 more source

Understanding Presumption System from Facial Images

, 2000
Atsushi Mimura, Masafumi Hagiwara
openalex   +2 more sources

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Safety and efficacy of a feed additive consisting of <i>Lacticaseibacillus huelsenbergensis</i> DSM 115424 for all animal species (Lactosan GmbH & Co. KG). [PDF]

EFSA J
EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), Villa RE, Azimonti G, Bonos E, Christensen H, Durjava M, Dusemund B, Gehring R, Glandorf B, Kouba M, López-Alonso M, Marcon F, Nebbia C, Pechová A, Prieto-Maradona M, Röhe I, Theodoridou K, Anguita M, Innocenti ML, García-Cazorla Y.   +19 more
europepmc   +1 more source

HIV disclosure to surrogate decision makers: privacy versus presumption [PDF]

, 2007
Jason P. Lott
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Reply to Rosenblum et al. and Carriquiry and Ommen: Understanding probative value, triers-of-fact, and usefulness of validity study results. [PDF]

Proc Natl Acad Sci U S A
Guyll M, Madon S, Yang Y, Burd KA, Wells G.   +4 more
europepmc   +1 more source

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Safety evaluation of the food enzyme α-amylase from the genetically modified <i>Bacillus licheniformis</i> strain DP-Dzb105. [PDF]

EFSA J
EFSA Panel on Food Enzymes (FEZ), Zorn H, Barat Baviera JM, Bolognesi C, Catania F, Gadermaier G, Greiner R, Mayo B, Mortensen A, Roos YH, Marzo Solano ML, Van Loveren H, Vernis L, Cabo LS, Liu Y.   +14 more
europepmc   +1 more source

Evaluation of Basic Physical and Chemical Properties of Amylose Extender Mutants of Rice for the Presumption of the Suitable Utilizations.

, 2001
Hitoshi Takahashi, Ken’ichi Ohtsubo, Marissa V. Romero, Hidechika TOYOSHIMA, Hiroshi Okadome, Aiko Nishi, Hikaru Sato   +6 more
openalex   +2 more sources